Skip to main content
Top
Published in: Surgical Endoscopy 1/2019

Open Access 01-01-2019

Short-term outcomes of transanal completion total mesorectal excision (cTaTME) for rectal cancer: a case-matched analysis

Authors: T. W. A. Koedam, M. Veltcamp Helbach, M. Penna, A. Wijsmuller, P. Doornebosch, H. L. van Westreenen, R. Hompes, H. J. Bonjer, C. Sietses, E. de Graaf, J. B. Tuynman

Published in: Surgical Endoscopy | Issue 1/2019

Login to get access

Abstract

Background

Local excision of early rectal tumors as a rectal preserving treatment is gaining popularity, especially since bowel cancer screening programs result in a shift towards the diagnosis of early stage rectal cancers. However, unfavorable histological features predicting high risk for recurrence within the “big biopsy” may mandate completion total mesorectal excision (cTME). Completion surgery is associated with higher morbidity, poorer specimen quality, and less favorable oncological outcomes compared to primary TME. Transanal approach potentially improves outcome of completion surgery for rectal cancer. The aim of this study was to compare radical completion surgery after local excision for rectal cancer by the transanal approach (cTaTME) with conventional abdominal approach (cTME).

Methods

All consecutive patients who underwent cTaTME for rectal cancer between 2012 and 2017 were case-matched with cTME patients, according to gender, tumor height, preoperative radiotherapy, and tumor stage. Surgical, pathological, and short-term postoperative outcomes were evaluated.

Results

In total, 25 patients underwent completion TaTME and were matched with 25 patients after cTME. Median time from local excision to completion surgery was 9 weeks in both groups. In the cTaTME and cTME groups, perforation of the rectum occurred in 4 and 28% of patients, respectively (p = 0.049), leading to poor specimen quality in these patients. Number of harvested lymph nodes was higher after cTaTME (median 15; range 7–47) than after cTME (median 10; range 0–17). No significant difference was found in end colostomy rate between the two groups. Major 30-day morbidity (Clavien–Dindo≥ III) was 20 and 32%, respectively (p = 0.321). Hospital stay was significantly longer after cTME.

Conclusion

TaTME after full-thickness excision is a promising technique with a significantly lower risk of perforation of the rectum and better specimen quality compared to conventional completion TME.
Literature
1.
go back to reference Hompes R, McDonald R, Buskens C et al (2013) Completion surgery following transanal endoscopic microsurgery: assessment of quality and short- and long-term outcome. Colorectal Dis 15:576–581CrossRef Hompes R, McDonald R, Buskens C et al (2013) Completion surgery following transanal endoscopic microsurgery: assessment of quality and short- and long-term outcome. Colorectal Dis 15:576–581CrossRef
2.
go back to reference Levic K, Bulut O, Hesselfeldt P et al (2013) The outcome of rectal cancer after early salvage TME following TAMIS compared with primary TME: a case-matched study. Tech Coloproctol 17:397–403CrossRefPubMed Levic K, Bulut O, Hesselfeldt P et al (2013) The outcome of rectal cancer after early salvage TME following TAMIS compared with primary TME: a case-matched study. Tech Coloproctol 17:397–403CrossRefPubMed
3.
go back to reference Van Gijn W, Brehm V, de graaf E et al (2013) Unexpected rectal cancer after TAMIS: outcome of completion surgery compared with primary TME. Eur J Surg Oncol 39:1225–1229CrossRefPubMed Van Gijn W, Brehm V, de graaf E et al (2013) Unexpected rectal cancer after TAMIS: outcome of completion surgery compared with primary TME. Eur J Surg Oncol 39:1225–1229CrossRefPubMed
4.
go back to reference Morino M, Allaix ME, Arolfo S et al (2013) Previous transanal endoscopic microsurgery for rectal cancer represents a risk factor for an increased abdominoperineal resection rate. Surg Endosc 27:3315–3321CrossRefPubMed Morino M, Allaix ME, Arolfo S et al (2013) Previous transanal endoscopic microsurgery for rectal cancer represents a risk factor for an increased abdominoperineal resection rate. Surg Endosc 27:3315–3321CrossRefPubMed
6.
go back to reference Lange MM, Maas CP, Marijnen CAM et al (2008) Urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg 95(8):1020–1028CrossRef Lange MM, Maas CP, Marijnen CAM et al (2008) Urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg 95(8):1020–1028CrossRef
7.
go back to reference Lange MM, den Dulk M, Bossema ER et al (2007) Risk factors for faecal incontinence after rectal cancer treatment. Br J Surg 94(10):1278–1284CrossRefPubMed Lange MM, den Dulk M, Bossema ER et al (2007) Risk factors for faecal incontinence after rectal cancer treatment. Br J Surg 94(10):1278–1284CrossRefPubMed
8.
go back to reference Lange MM, Marijnen CAM, Maas CP et al (2009) Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer 45(9):1578–1588CrossRefPubMed Lange MM, Marijnen CAM, Maas CP et al (2009) Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer 45(9):1578–1588CrossRefPubMed
9.
go back to reference Lee W, Lee D, Choi S, Chun H (2003) Transanal endoscopic microsurgery and radical surgery for T1 and T2 rectal cancer. Surg Endosc 17(8):1283–1287CrossRefPubMed Lee W, Lee D, Choi S, Chun H (2003) Transanal endoscopic microsurgery and radical surgery for T1 and T2 rectal cancer. Surg Endosc 17(8):1283–1287CrossRefPubMed
10.
go back to reference Sengupta S, Tjandra JJ (2001) Local excision of rectal cancer: what is the evidence? Dis Colon Rectum 44(9):1345–1361CrossRefPubMed Sengupta S, Tjandra JJ (2001) Local excision of rectal cancer: what is the evidence? Dis Colon Rectum 44(9):1345–1361CrossRefPubMed
11.
go back to reference Borschitz T, Heintz A, Junginger T (2007) Transanal endoscopic microsurgical excision of pT2 rectal cancer: results and possible indications. Dis Colon Rectum 50(3):292–301CrossRefPubMed Borschitz T, Heintz A, Junginger T (2007) Transanal endoscopic microsurgical excision of pT2 rectal cancer: results and possible indications. Dis Colon Rectum 50(3):292–301CrossRefPubMed
12.
go back to reference Bach SP, Hill J, Monson JRT, Transanal endoscopic microsurgery (TEM) Collaboration et al (2009) A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg 96:280–290CrossRefPubMed Bach SP, Hill J, Monson JRT, Transanal endoscopic microsurgery (TEM) Collaboration et al (2009) A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg 96:280–290CrossRefPubMed
13.
go back to reference Van de Velde CJ, Aristei C, Boelens PG et al (2014) EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. Eur J Cancer 50(1):1.e1–1.e34CrossRef Van de Velde CJ, Aristei C, Boelens PG et al (2014) EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. Eur J Cancer 50(1):1.e1–1.e34CrossRef
14.
go back to reference Benson AB, Venook AP, Bekaii-Saab T et al (2013) NCCN clinical practice guidelines in oncology: rectal cancer, version 2. J Natl Compr Cancer Netw 13(6):719–728CrossRef Benson AB, Venook AP, Bekaii-Saab T et al (2013) NCCN clinical practice guidelines in oncology: rectal cancer, version 2. J Natl Compr Cancer Netw 13(6):719–728CrossRef
16.
go back to reference De Lacy AM, Rattner DW, Adelsdorfer C et al (2013) Transanal natural orifice transluminal endoscopic surgery (NOTES) rectal resection: “down-to up” total mesorectal excision (TME)—short-term outcomes in the first 20 cases. Surg Endosc 27:3165–3172CrossRefPubMed De Lacy AM, Rattner DW, Adelsdorfer C et al (2013) Transanal natural orifice transluminal endoscopic surgery (NOTES) rectal resection: “down-to up” total mesorectal excision (TME)—short-term outcomes in the first 20 cases. Surg Endosc 27:3165–3172CrossRefPubMed
17.
go back to reference Nagtegaal I, van de Veld CJH, van der Worp E et al (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20:1729–1734CrossRefPubMed Nagtegaal I, van de Veld CJH, van der Worp E et al (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20:1729–1734CrossRefPubMed
18.
go back to reference Vlek SL, Lier MCI, Koedam TWA, Melgers I, Dekker JJML, Bonjer JH, Mijatovic V, Tuynman JB (2017) Transanal minimally invasive rectal resection for deep endometriosis: a promising technique. Colorectal Dis 19(6):576–581CrossRefPubMed Vlek SL, Lier MCI, Koedam TWA, Melgers I, Dekker JJML, Bonjer JH, Mijatovic V, Tuynman JB (2017) Transanal minimally invasive rectal resection for deep endometriosis: a promising technique. Colorectal Dis 19(6):576–581CrossRefPubMed
19.
20.
go back to reference Phil Quirke P, Steele R, John Monson J et al (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373:821–828CrossRefPubMedPubMedCentral Phil Quirke P, Steele R, John Monson J et al (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373:821–828CrossRefPubMedPubMedCentral
21.
go back to reference Eriksen MT, Wibe A, Syse A, Heffner J, Wiig JN, Norwegian Rectal Cancer Group, Norwegian Gastrointestinal Cancer Group (2004) Inadvertent perforation during rectal cancer resection in Norway. Br J Surg 91:210–216CrossRef Eriksen MT, Wibe A, Syse A, Heffner J, Wiig JN, Norwegian Rectal Cancer Group, Norwegian Gastrointestinal Cancer Group (2004) Inadvertent perforation during rectal cancer resection in Norway. Br J Surg 91:210–216CrossRef
22.
go back to reference Deijen CL, Tsai A, Koedam TW, Veltcamp Helbach M, Sietses C, Lacy AM, Bonjer HJ, Tuynman JB (2016) Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol 20(12):811–824CrossRefPubMedPubMedCentral Deijen CL, Tsai A, Koedam TW, Veltcamp Helbach M, Sietses C, Lacy AM, Bonjer HJ, Tuynman JB (2016) Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol 20(12):811–824CrossRefPubMedPubMedCentral
23.
go back to reference Veltcamp Helbach M, Deijen CL, Velthuis S et al (2016) Transanal total mesorectal excision for rectal carcinoma: short-term outcomes and experience after 80 cases. Surg Endosc 30:464–470CrossRefPubMed Veltcamp Helbach M, Deijen CL, Velthuis S et al (2016) Transanal total mesorectal excision for rectal carcinoma: short-term outcomes and experience after 80 cases. Surg Endosc 30:464–470CrossRefPubMed
24.
go back to reference Van der Pas MHGM, Haglind E, Cuesta MA et al (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomized, phase 3 trial. Lancet Oncol 14(3):210–218CrossRefPubMed Van der Pas MHGM, Haglind E, Cuesta MA et al (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomized, phase 3 trial. Lancet Oncol 14(3):210–218CrossRefPubMed
25.
go back to reference Motson RW, Whiteford MH, Hompes R et al (2016) Current status of trans-anal total mesorectal excision (TaTME) following the Second International Consensus Conference. Colorectal Dis 18(1):13–18CrossRefPubMed Motson RW, Whiteford MH, Hompes R et al (2016) Current status of trans-anal total mesorectal excision (TaTME) following the Second International Consensus Conference. Colorectal Dis 18(1):13–18CrossRefPubMed
26.
go back to reference Borstlap WA, Tanis PJ, Koedam TW et al (2016 Jul) A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer. BMC Cancer 16:513CrossRefPubMedPubMedCentral Borstlap WA, Tanis PJ, Koedam TW et al (2016 Jul) A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer. BMC Cancer 16:513CrossRefPubMedPubMedCentral
Metadata
Title
Short-term outcomes of transanal completion total mesorectal excision (cTaTME) for rectal cancer: a case-matched analysis
Authors
T. W. A. Koedam
M. Veltcamp Helbach
M. Penna
A. Wijsmuller
P. Doornebosch
H. L. van Westreenen
R. Hompes
H. J. Bonjer
C. Sietses
E. de Graaf
J. B. Tuynman
Publication date
01-01-2019
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 1/2019
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-018-6280-3

Other articles of this Issue 1/2019

Surgical Endoscopy 1/2019 Go to the issue